@platinumstandard did set the record, errm, straight: to classify AVR as a biotech stock is just plain wrong.
I assume the Anteris Wikipedia page is written by Anteris' publicity, or at the very least monitored by them:
From Wikipedia, the free encyclopedia
Anteris Technologies Limited is an Australian biotechnology company.
I could cite other sources, but If Anteris is not a Australian Biotech then I have failed to grasp the meaning of either word.
As for the opinion I expressed about risk etc, I stand by that too.
Regards,
P
TAVR MARKET Superiority, page-86
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.99 |
Change
0.790(5.98%) |
Mkt cap ! $285.3M | |||
| Open | High | Low | Value | Volume |
| $13.08 | $14.00 | $12.84 | $79.46K | 6.006K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 132 | $13.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.99 | 458 | 2 |
View Market Depth
| Last trade - 14.40pm 29/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |